9 November 2018 - Deborah Wilkes
Archived
Worldwide sales at GlaxoSmithKline's Consumer Healthcare business increased by 3% at constant exchange rates in the third quarter of 2018, as sales declined in Europe but grew in the US and International markets.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.